RECURRENT PROSTATE CARCINOMA
Clinical trials for RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can switching PARP inhibitors outsmart cancer? new trial aims to find out
Disease control Recruiting nowThis study is testing a drug called talazoparib in people with advanced solid tumors that have specific DNA repair gene mutations. The goal is to see if this PARP inhibitor can shrink tumors or slow their growth, even in patients who have already tried a similar drug. About 36 ad…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:07 UTC
-
New study tests fasting and Weight-Loss drugs to shield hearts during prostate cancer treatment
Disease control Recruiting nowThis study looks at whether time-restricted eating (intermittent fasting) or GLP-1 medications (semaglutide, tirzepatide) can reduce heart risks in prostate cancer patients receiving hormone therapy. About 60 men will be randomly assigned to one of these approaches or a standard …
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Heart-Safe prostate cancer treatment? new trial pits two hormone drugs against each other
Disease control Recruiting nowThis study compares two hormone therapy combinations for men with advanced prostate cancer who are also getting radiation. The goal is to see which combination causes less damage to the heart and blood vessels. Participants will be randomly assigned to receive either leuprolide o…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Scientists hunt for clues to cancer drug resistance in new study
Knowledge-focused Recruiting nowThis study collects tissue and blood samples from 1,500 people with prostate or bladder cancer that has returned or spread. Researchers will analyze the samples to find genetic changes and other markers that explain why some cancers stop responding to treatment. The goal is to di…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
New imaging agent may help surgeons spot hidden prostate cancer
Knowledge-focused Recruiting nowThis early study tests a radioactive imaging agent called 99mTc-PSMA-I&S in 30 men with prostate cancer who are scheduled for lymph node removal surgery. The goal is to see how the agent spreads in the body and whether it can help surgeons detect cancer that has spread to lymph n…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC